Does ADALIMUMAB Cause Hepatic cirrhosis? 1,760 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,760 reports of Hepatic cirrhosis have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.4% of all adverse event reports for ADALIMUMAB.
1,760
Reports of Hepatic cirrhosis with ADALIMUMAB
0.4%
of all ADALIMUMAB reports
598
Deaths
708
Hospitalizations
How Dangerous Is Hepatic cirrhosis From ADALIMUMAB?
Of the 1,760 reports, 598 (34.0%) resulted in death, 708 (40.2%) required hospitalization, and 398 (22.6%) were considered life-threatening.
Is Hepatic cirrhosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 1,760 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Hepatic cirrhosis?
METHOTREXATE (1,650)
ETANERCEPT (931)
TOCILIZUMAB (903)
RITUXIMAB (863)
INFLIXIMAB (831)
ABATACEPT (824)
HYDROXYCHLOROQUINE (807)
LEFLUNOMIDE (780)
SULFASALAZINE (760)
USTEKINUMAB (753)
Which ADALIMUMAB Alternatives Have Lower Hepatic cirrhosis Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB